Jul 21, 2021 8:30am EDT Ladenburg Thalmann to Host R&D Showcase Featuring Artelo Biosciences’ CAReS Study on July 28, 2021
Jul 12, 2021 8:30am EDT Artelo Biosciences Reports Third Quarter Fiscal 2021 Financial Results and Provides Business Update
Jul 07, 2021 8:30am EDT Artelo Biosciences to Present at the 2021 Ladenburg Thalmann Healthcare Conference on July 14th
Jun 22, 2021 8:00am EDT Artelo Biosciences Announces Two Poster Presentations Featured at the 31st Annual ICRS Symposium
Jun 02, 2021 8:30am EDT Artelo Biosciences to Present at the LD Micro Virtual Invitational XI on June 9th
May 06, 2021 10:00am EDT Artelo Biosciences to Participate at the Benzinga Global Small Cap Conference on May 13, 2021
Apr 13, 2021 8:30am EDT Artelo Biosciences Reports Second Quarter Fiscal 2021 Financial Results and Provides Business Update
Apr 12, 2021 8:30am EDT Artelo Biosciences Doses First Patient in CAReS Study with ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
Mar 19, 2021 10:00am EDT Artelo Biosciences Accepted into the Alderley Park Oncology Development Program for FABP5 Inhibitor Biomarker Development
Mar 11, 2021 7:10am EST Artelo Biosciences, Inc. to Present at the Q1 Virtual Investor Summit on March 23rd
